Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.
Department of Surgery, Division of Surgical Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Skye C
SC
Mayo
Joseph M
JM
Herman
David
D
Cosgrove
Nik
N
Bhagat
Ihab
I
Kamel
Jean-Francois H
JF
Geschwind
Timothy M
TM
Pawlik
D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017115:Catheter Ablation; D016461:Chemoembolization, Therapeutic; D059186:Chemoradiotherapy, Adjuvant; D006498:Hepatectomy; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000556:secondary* / Q000628:therapy*; D016031:Liver Transplantation; D058990:Molecular Targeted Therapy; D009367:Neoplasm Staging; D018358:Neuroendocrine Tumors / Q000175:diagnosis / Q000401:mortality / Q000556:secondary* / Q000628:therapy*; D016896:Treatment Outcome
D000970:Antineoplastic Agents